X-Genix

X-Genix is a biotechnology company developing enzyme-enabled methods for selective molecular modification in drug discovery.

Its platform integrates engineered biological catalysts, synthetic chemistry and machine learning to modify small molecules and complex biomolecules at defined sites. This provides access to chemical structures that can be difficult to produce using conventional synthesis.

The company explores therapeutic molecule design and targeted delivery, seeking partners to translate its molecular editing technology into drug discovery programmes.